VALID Trial

Vascular Access outcome measure for function: a vaLidation study In haemodialysis (VALID)

Principal Investigators: Andrea Viecelli
Clinical Project Manager: Liza Vergara (AKTN)
Clinical Research Associate: Andrea Valks (AKTN)
Trial Number: AKTN 19.01

Population: Patients 18 years old or over who are new to or established on chronic haemodialysis
Follow-up: 6 months
Primary outcome: Reporting of vascular access function during a 6 months period, defined by the need for any intervention(s) required to enable and maintain the use of a vascular access for HD

Status: Recruitment to commence 2nd Q 2019
Target Recruitment: 612 participants across 10 centres across Australia, Europe, Canada, USA, China and Malaysia


Trial Summary

VALID is a prospective, multi-centre, multinational validation study to assess the accuracy and feasibility of measuring vascular access function, defined as the need for interventions to enable and maintain the use of a vascular access for HD, by clinical staff as part of their routine clinical practice.

The study aims to assess the accuracy of collecting vascular access interventions required to enable and maintain the use of a vascular access for HD collected by clinical staff as part of routine clinical practice. It also aims to assess the feasibility of collecting vascular access interventions required to enable and maintain the use of a vascular access for HD as part of routine clinical practice.

The study has already received funding from the Jacquot Research Establishment Grant and a Princess Alexandra Research Foundation 2019 Research Award.